About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 73 record(s)
Nothing to report this month
Organization: Royal Canadian Mint
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-001
Records dated February 2, 2020 to April 14, 2020 concerning coin minting operations during the COVID-19 outbreak, including extra costs on the handling of coins and distribution during the outbreak.Organization: Royal Canadian Mint
September 2020
Req # A-2020-002
Records dated January 7, 2020 to April 14, 2020 concerning plans and procedures in place regarding the production of new coins (circulation and numismatic) that would have a different effigy should Queen Elizabeth II be deceased, the replacement of any coins (circulation and numismatic) currently bearing the Queen’s image should Queen Elizabeth II be deceased, and estimates of the amount of each coin in circulation bearing her image.Organization: Royal Canadian Mint
September 2020
Nothing to report this month
Organization: Canada Energy Regulator
Nothing to report this month
Organization: Canada Hibernia Holding Corporation
Nothing to report this month
Organization: Yukon Environmental and Socio-economic Assessment Board
Req # A-2020-00008
This message is to request information related CNSC contract/solicitation 5147679-87055-16-0298. We ask that you please provide us with the number of bidders, along with the median rates for each category of service.Organization: Canada Energy Regulator
August 2020